VC-backed TubeMogul cuts IPO pricing terms

According to an amended SEC filing, TubeMogul has reduced its IPO pricing terms. It now plans on selling its IPO of 6.25 million shares between $7 and $8 per share as opposed to an earlier intention of selling it between $11 and $13 per share. The stock will list on the NASDAQ under the ticker symbol “TUBE.” BofA Merrill Lynch, Citigroup, RBC Capital Markets, BMO Capital Markets and Oppenheimer & Co. will serve as lead underwriters. Based in Emeryville, Calif., TubeMogul is an online video marketing company. Its backers include SingTel Innov8, Cross Creek Capital, Digital Advertising Consortium, Foundation Capital and Trinity Ventures.

breakfast pizza
484 Views

peHUB Second Opinion

In Second Opinion, Nordstrom is in talks to buy Trunk Club, LeBron James return to the Cleveland Cavaliers will have a $500 million a year impact on the local economy, plus Tim Armstrong would love to merge AOL – Yahoo but Marissa Mayer isn’t backing it. Also, should pizza places shouldn’t serve brunch? No!

361 Views

Riverstone forms energy credit team

Riverstone Holdings has formed a team of energy-focused leveraged finance professionals to lead the firm’s expansion into credit and capital markets activities. The team includes Christopher Abbate, former managing director and head of energy leveraged finance at Citigroup; Jamie Brodsky and Daniel Flannery, who both join Riverstone from Nomura Securities International. All three also worked together on the energy leveraged finance team at UBS.

VC-backed TubeMogul sets pricing terms for IPO

According to an amended SEC filing, TubeMogul has priced its IPO of 6.25 million shares between $11 and $13 per share. Also, the company plans on listing the stock on the NASDAQ under the ticker symbol “TUBE.” BofA Merrill Lynch, Citigroup, RBC Capital Markets, BMO Capital Markets and Oppenheimer & Co. will serve as lead underwriters. Based in Emeryville, Calif., TubeMogul is an online video marketing company. Its backers include SingTel Innov8, Cross Creek Capital, Digital Advertising Consortium, Foundation Capital and Trinity Ventures.

OMAM files for IPO

Boston-based OM Asset Management has filed for an IPO. The number of shares that will be sold as well as the stock’s pricing terms have yet to be set. BofA Merrill Lynch, Morgan Stanley, Citigroup and Credit Suisse Securities (USA) are the lead underwriters. OMAM is the newly formed holding company for Old Mutual‘s US-based institutional asset management business.

VC-backed Ardelyx debuts IPO

Ardelyx has launched its IPO after pricing its approximately 4.3 million shares at $14 per share. The stock began trading Thursday on the NASDAQ under the ticker symbol “ARDX.” Citigroup and Leerink Partners are the lead underwriters. Based in Fremont, Calif., Ardelyx is a biopharmaceutical firm focused on cardio-renal, GI and metabolic diseases. Its backers include New Enterprise Associates, CMEA Capital and Amgen Ventures.

06052014coins5x
633 Views

Banks face U.S. fines over LBO loans: Reuters

Wall Street banks are bracing for a clampdown and even fines if regulators determine they have violated guidelines aimed at stamping out reckless underwriting on leveraged buyout debt, according to Thomson Reuters International Financing Review and Thomson Reuters Loan Pricing Corp.

268 Views

Bain Capital-backed Trinseo prices IPO

Trinseo SA, a plastics maker that is backed by Bain Capital, has priced its IPO of 10 million shares at between $17 and $19 per share. The company plans on listing the stock on the NYSE under the ticker symbol “TSE.” Goldman Sachs, Deutsche Bank Securities, Citigroup and Morgan Stanley are serving as lead underwriters.

261 Views

Khosla Ventures and ex-Citigroup CEO Pandit back Fundbox

San Francisco-based risk engine creator Fundbox has raised $17.5 million in funding. Khosla Ventures led the round with participation from investors that included SV Angels, former Citigroup CEO Vikram Pandit and former Thomson Reuters CEO Tom Glocer.

126 Views

VC-backed Versartis raises $126 mln for IPO

Versartis has launched its IPO after pricing its 6 million shares at $21 per share. The stock began trading Friday on the NASDAQ under the ticker symbol “VSAR.” Morgan Stanley and Citigroup are the lead underwriters. Based in Redwood City, Calif., Versartis is an endocrine-focused biopharmaceutical company focused on treating growth hormone deficiency. Its backers include Sofinnova Ventures, Aisling Capital, New Leaf Venture Partners and Advent Life Sciences.

PEHUB Community

Join the 12500 members of peHUB to make connections, share your opinion, and follow your favorite authors.

Join the Community

Look Who’s Tweeting

Psst! Got any hot tips?

  • This field is for validation purposes and should be left unchanged.

PE HUB News Briefs

RSS Feed Widget

Marketplace

VCJ Headlines (subscribers only)

RSS Feed Widget

Buyouts Headlines (subscribers only)

RSS Feed Widget

Reuters VC and PE feed

RSS Feed Widget